anmelden
FTSE All-Share
5.842,37
PKT
+16,28
PKT
+0,28
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.01.19 | Vodafone Group Underperform | Macquarie Research | |
| 09.01.19 | BP overweight | Morgan Stanley | |
| 09.01.19 | Shell (ex Royal Dutch Shell) Equal-Weight | Morgan Stanley | |
| 09.01.19 | BP buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.01.19 | Shell (ex Royal Dutch Shell) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.01.19 | BP buy | UBS AG | |
| 09.01.19 | HSBC Underweight | Barclays Capital | |
| 08.01.19 | Prudential Neutral | JP Morgan Chase & Co. | |
| 08.01.19 | Unilever Neutral | UBS AG | |
| 08.01.19 | Unilever Neutral | UBS AG | |
| 08.01.19 | Vodafone Group Underperform | RBC Capital Markets | |
| 07.01.19 | Prudential buy | Deutsche Bank AG | |
| 07.01.19 | Barclays buy | UBS AG | |
| 07.01.19 | Lloyds Banking Group buy | UBS AG | |
| 07.01.19 | HSBC Neutral | UBS AG | |
| 07.01.19 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.01.19 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 04.01.19 | Rio Tinto buy | UBS AG | |
| 04.01.19 | BP buy | UBS AG | |
| 04.01.19 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 04.01.19 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 04.01.19 | Glencore Neutral | UBS AG | |
| 04.01.19 | Diageo Underperform | Bernstein Research | |
| 04.01.19 | BP kaufen | RBC Capital Markets | |
| 04.01.19 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.01.19 | GSK buy | UBS AG | |
| 02.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.12.18 | National Grid Neutral | Credit Suisse Group | |
| 20.12.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.12.18 | Lloyds Banking Group Outperform | RBC Capital Markets | |
| 20.12.18 | HSBC Underperform | RBC Capital Markets | |
| 20.12.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.12.18 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 20.12.18 | GSK Hold | Deutsche Bank AG | |
| 19.12.18 | GSK buy | Goldman Sachs Group Inc. | |
| 19.12.18 | BP Outperform | Credit Suisse Group | |
| 19.12.18 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 18.12.18 | BAT overweight | Barclays Capital | |
| 18.12.18 | BAT Outperform | Credit Suisse Group | |
| 18.12.18 | Vodafone Group buy | Deutsche Bank AG |
